Review of case report discusses anti-PL-12 antisynthetase syndrome and NK/T-cell non-Hodgkin lymphomaPatient with anti-PL-12 syndrome and lymphoma: a rare case report

This publication is a review of a case report involving a patient with anti-PL-12 antisynthetase syndrome. The scope of the document focuses on the co-occurrence of this autoimmune condition with NK/T-cell non-Hodgkin lymphoma. No specific intervention, comparator, or primary outcome data are provided as these were not reported in the source material. The setting and follow-up duration were also not reported.

The authors highlight a critical gap in current knowledge, stating that data on the association between antisynthetase syndrome (ASS) and malignancy remain very limited. While patients with inflammatory myopathies generally carry an increased risk of developing neoplasms, most commonly adenocarcinoma, the literature does not support a similar association with lymphoma or other hematologic malignancies. This specific case adds to the limited pool of information regarding this rare overlap.

Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported in the source. Consequently, the practice relevance of this single case is difficult to generalize. Clinicians should interpret these findings conservatively, recognizing that the evidence base for this specific association is extremely small and observational in nature.